Suven LifeSciences

Suven LifeSciences has got 2 patents for CNS Drugs in Australia and Russia.

Suven completes phase I dose study on new drug

Astec LifeSciences plans IPO, files DRHP with SEBI

Nectar Lifesciences declares 20% dividend

This entry was posted on Wednesday, May 28th, 2008 at 2:16 pm and is filed under Indian Stock Market News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Indian Stock Market

Suven LifeSciences

Leave a Reply

Categories

Archives

Feed

Links

Subscribe by E-Mail :

Recent Posts

Recent Comments

Indian Stock Market News